This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

University Of Missouri Thompson Center For Autism And Neurodevelopmental Disorders Selects Prometheus Research To Build Integrated Autism Database

NEW HAVEN, Conn., Oct. 15, 2012 /PRNewswire/ -- Prometheus Research, a leading provider of integrated data management services for behavioral and biomedical research, announced today that it has been selected by the University of Missouri to support the data management initiatives of their Thompson Center for Autism and Neurodevelopmental Disorders.  Prometheus Research will leverage the technology already in place from their mutual involvement in the Simons Simplex Collection (SSC) to create an integrated data management system.  The new system will support research beyond the SSC in Missouri.

The Thompson Center currently supports over 30 studies pertaining to the identification and treatment of individuals with Autism Spectrum Disorders. As a data management services client, the Thompson Center receives support from Prometheus in every major dimension of data management including data collection, data quality reporting, query definition, data integration, and data set generation.  Prometheus provides the flexibility to ramp up or ramp down service levels on a quarterly basis. 

"We're very excited to be working with yet another prestigious institution participating in multidisciplinary and collaborative research.  We look forward to helping the Autism Research Core make new discoveries related to ASD and neurodevelopmental disorders," said COO David Voccola.

About Prometheus ResearchPrometheus Research's mission is to help research institutions and funding organizations get more value from their data.  Prometheus offers integrated data management services, expert consulting, and software customization to deliver sensible solutions powered by their adaptable, web-based RexDB® technology.  Prometheus' unique combination of technical skill and deep domain knowledge make them an ideal partner for building centralized data repositories, supporting multidisciplinary collaborations, and securely sharing sensitive data.  Several of Prometheus' inventions have made significant advances in the areas of data acquisition, integration, curation, and exploration including the open source query language, RexQL (formerly HTSQL), and the Open Source Research Exchange Database, OSRexDB®.  Prometheus has received several awards in 2011-2012 including Best Places to Work in Connecticut, Marcum Tech Top 40, Inc's Top 500|5000, and CNN Money's top 100 fastest growing inner city companies.

Prometheus is proud to serve some of the most ambitious research endeavors in the world including the Simons Foundation Autism Research Initiative (SFARI), Autism Speaks, the Marcus Autism Center, and the Yale University Child Study Center.

To learn more about how integrated data management can be used to support research projects, visit www.PrometheusResearch.com.

About the Thompson Center for Autism and Neurodevelopmental DisordersThe Thompson Center for Autism and Neurodevelopmental Disorders at the University of Missouri is a national leader in confronting the challenges of autism and other developmental conditions through its collaborative research, training and service programs. For additional information, visit http://thompsoncenter.missouri.edu.

SOURCE Prometheus Research

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs